Upadacitinib, an oral selective Janus kinase (JAK) inhibitor, is used to treat moderate-to-severe atopic dermatitis (AD). Acne is the most common treatment-emergent adverse event in patients with AD treated with upadacitinib. In this post hoc analysis, we describe the acne events in ...
Essential Treatment Tips for Textured Hair Experts Weigh in on Best Body-Focused Skin Care How to Explain JAK Inhibitor Warnings to Patients Get to the Roots of Pediatric Acne Legal and Tax Options for a Practice’s Structure Cosmetic Conundrums & Cleansing Complexities OSHA, the Needle, and the...
The present disclosure relates generally to novel molecules, compositions, and formulations for treatment of bacterial infections in general and more specifically to bacterial infections with antibiotic resistant pathogensInventors: Sengupta, Shiladitya (Delhi, IN) Chawrai, Suresh Rameshlal (Pune, IN) ...
Case report: successful treatment of refractory SAPHO syndrome with the JAK inhibitor tofacitinib. Medicine. 2018;97 (25):e11149. doi:10.1097/MD.0000000000011149 26. Yuan F, Luo J, Yang Q. SAPHO syndrome complicated by ankylosing spondylitis successfully treated with tofacitinib: a case report. ...
Conclusions and Relevance: In this systematic review and meta-analysis, JAK inhibitor use was associated with an elevated odds of acne. Patients should be properly counseled on this potential adverse effect of these medications before treatment initiation. Future studies are...
TERMINATION of treatmentALOPECIA areataThe article explores JAK inhibitor-associated acne (JAK-acne) in Chinese patients with alopecia areata (AA) treated with tofacitinib. The study reviews medical records of AA patients treated with tofacitinib, with 19.8% developing JAK-acne. Patients ...
PREGNANCY outcomesSYNOVITISOSTEITISEXOSTOSISUNPLANNED pregnancyPREGNANT womenSYNDROMESThis article discusses the use of tofacitinib, an oral Janus kinase (JAK) inhibitor, for the treatment of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome, a rare autoinflammatory disease. Tofacitinib...
Case report: successful treatment of refractory SAPHO syndrome with the JAK inhibitor tofacitinib. Medicine. 2018;97 (25):e11149. doi:10.1097/MD.0000000000011149 26. Yuan F, Luo J, Yang Q. SAPHO syndrome complicated by ankylosing spondylitis successfully treated with tofacitinib: a case report. ...
Gram-negative folliculitis in patients with acne who experience a worsening of pustular or cystic lesions while on antibiotics, and in individuals who fail to see significant improvement in their acne after 3 to 6 months of antibiotic therapy. The preferred treatment for Gram-negative folliculitis ...
This review provides a starting point for further studies aimed at investigating the role of miRNAs in AV and HS for their possible use as diagnostic-therapeutic targets. Keywords: hidradenitis suppurativa; acne; mirnas; skin; inflammation; cytokines; biologic therapy; diagnosis; treatment...